HFCAS OpenIR
Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc
Bian,Erbao1,2; Chen,Xueran3,4; Cheng,Li5; Cheng,Meng1,2; Chen,Zhigang1,2; Yue,Xiaoyu1,2; Zhang,Zhengwei1,2; Chen,Jie1,2; Sun,Libo1,2; Huang,Kebing1,2; Huang,Cheng5; Fang,Zhiyou3,4; Zhao,Bing1,2; Li,Jun5
2021-10-25
发表期刊Journal of Experimental & Clinical Cancer Research
通讯作者Bian,Erbao(bianerbao@ahmu.edu.cn) ; Fang,Zhiyou(z.fang@cmpt.ac.cn) ; Zhao,Bing(aydzhb@126.com) ; Li,Jun(lj@ahmu.edu.cn)
摘要AbstractBackgroundLong non-coding RNAs (lncRNAs) have been considered as one type of gene expression regulator for cancer development, but it is not clear how these are regulated. This study aimed to identify a specific lncRNA that promotes glioma progression.MethodsRNA sequencing (RNA-seq) and quantitative real-time PCR were performed to screen differentially expressed genes. CCK-8, transwell migration, invasion assays, and a mouse xenograft model were performed to determine the functions of TMEM44-AS1. Co-IP, ChIP, Dual-luciferase reporter assays, RNA pulldown, and RNA immunoprecipitation assays were performed to study the molecular mechanism of TMEM44-AS1 and the downstream target.ResultsWe identified a novel lncRNA TMEM44-AS1, which was aberrantly expressed in glioma tissues, and that increased TMEM44-AS1 expression was correlated with malignant progression and poor survival for patients with glioma. Expression of TMEM44-AS1 increased the proliferation, colony formation, migration, and invasion of glioma cells. Knockdown of TMEM44-AS1 in glioma cells reduced cell proliferation, colony formation, migration and invasion, and tumor growth in a nude mouse xenograft model. Mechanistically, TMEM44-AS1 is directly bound to the SerpinB3, and sequentially activated Myc and EGR1/IL-6 signaling; Myc transcriptionally induced TMEM44-AS1 and directly bound to the promoter and super-enhancer of TMEM44-AS1, thus forming a positive feedback loop with TMEM44-AS. Further studies demonstrated that Myc interacts with MED1 regulates the super-enhancer of TMEM44-AS1. More importantly, a novel small-molecule Myc inhibitor, Myci975, alleviated TMEM44-AS1-promoted the growth of glioma cells.ConclusionsOur study implicates a crucial role of the TMEM44-AS1-Myc axis in glioma progression and provides a possible anti-glioma therapeutic agent.
关键词Glioma lncRNA TMEM44-AS1 Super-enhancer Myc
DOI10.1186/s13046-021-02129-9
语种英语
WOS记录号BMC:10.1186/s13046-021-02129-9
出版者BioMed Central
引用统计
文献类型期刊论文
条目标识符http://ir.hfcas.ac.cn:8080/handle/334002/125662
专题中国科学院合肥物质科学研究院
通讯作者Bian,Erbao; Fang,Zhiyou; Zhao,Bing; Li,Jun
作者单位1.The Second Affiliated Hospital of Anhui Medical University; Department of Neurosurgery
2.Anhui Medical University; Cerebral Vascular Disease Research Center
3.Chinese Academy of Sciences; Department of Laboratory Medicine, Hefei Cancer Hospital
4.Hefei Institutes of Physical Science, Chinese Academy of Sciences; Anhui Province Key Laboratory of Medical Physics and Technology; Institute of Health and Medical Technology
5.Anhui Medical University; School of pharmacy
推荐引用方式
GB/T 7714
Bian,Erbao,Chen,Xueran,Cheng,Li,et al. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc[J]. Journal of Experimental & Clinical Cancer Research,2021,40.
APA Bian,Erbao.,Chen,Xueran.,Cheng,Li.,Cheng,Meng.,Chen,Zhigang.,...&Li,Jun.(2021).Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc.Journal of Experimental & Clinical Cancer Research,40.
MLA Bian,Erbao,et al."Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc".Journal of Experimental & Clinical Cancer Research 40(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bian,Erbao]的文章
[Chen,Xueran]的文章
[Cheng,Li]的文章
百度学术
百度学术中相似的文章
[Bian,Erbao]的文章
[Chen,Xueran]的文章
[Cheng,Li]的文章
必应学术
必应学术中相似的文章
[Bian,Erbao]的文章
[Chen,Xueran]的文章
[Cheng,Li]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。